Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

Pierluigi Tricoci, Zhen Huang, Claes Held, David J. Moliterno, Paul W. Armstrong, Frans Van De Werf, Harvey D. White, Philip E. Aylward, Lars Wallentin, Edmond Chen, Yuliya Lokhnygina, Jinglan Pei, Sergio Leonardi, Tyrus L. Rorick, Ann M. Kilian, Lisa H.K. Jennings, Giuseppe Ambrosio, Christoph Bode, Angel Cequier, Jan H. CornelRafael Diaz, Aycan Erkan, Kurt Huber, Michael P. Hudson, Lixin Jiang, J. Wouter Jukema, Basil S. Lewis, A. Michael Lincoff, Gilles Montalescot, José Carlos Nicolau, Hisao Ogawa, Matthias Pfisterer, Juan Carlos Prieto, Witold Ruzyllo, Peter R. Sinnaeve, Robert F. Storey, Marco Valgimigli, David J. Whellan, Petr Widimsky, John Strony, Robert A. Harrington, Kenneth W. Mahaffey

Research output: Contribution to journal › Article › peer-review

695 Scopus citations

Fingerprint

Dive into the research topics of 'Thrombin-receptor antagonist vorapaxar in acute coronary syndromes'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science